143 related articles for article (PubMed ID: 38302313)
1. Vaccinations in patients with chronic lymphocytic leukemia.
Francis ER; Vu J; Perez CO; Sun C
Semin Hematol; 2024 Apr; 61(2):131-138. PubMed ID: 38302313
[TBL] [Abstract][Full Text] [Related]
2. Effects of the BTN162b2 mRNA COVID-19 vaccine in humoral and cellular immunity in patients with chronic lymphocytic leukemia.
Fiorcari S; Atene CG; Maffei R; Mesini N; Debbia G; Colasante C; Pozzi S; Barbieri E; Maccaferri M; Leonardi G; Potenza L; Luppi M; Marasca R
Hematol Oncol; 2023 Feb; 41(1):120-127. PubMed ID: 36156278
[TBL] [Abstract][Full Text] [Related]
3. Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis.
Muchtar E; Koehler AB; Johnson MJ; Rabe KG; Ding W; Call TG; Leis JF; Kenderian SS; Hayman SR; Wang Y; Hampel PJ; Holets MA; Darby HC; Slager SL; Kay NE; Miao C; Canniff J; Whitaker JA; Levin MJ; Schmid DS; Kennedy RB; Weinberg A; Parikh SA
Am J Hematol; 2022 Jan; 97(1):90-98. PubMed ID: 34699616
[TBL] [Abstract][Full Text] [Related]
4. Improved plasmablast response after repeated pneumococcal revaccinations following primary immunization with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia.
Kättström M; Uggla B; Tina E; Kimby E; Norén T; Athlin S
Vaccine; 2023 May; 41(19):3128-3136. PubMed ID: 37061372
[TBL] [Abstract][Full Text] [Related]
5. Vaccination efficacy in patients with chronic lymphocytic leukemia.
Wang KY; Shah P; Skavla B; Fayaaz F; Chi J; Rhodes JM
Leuk Lymphoma; 2023 Jan; 64(1):42-56. PubMed ID: 36270021
[TBL] [Abstract][Full Text] [Related]
6. Response to anti-SARS-CoV-2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patients.
Zaleska J; Kwasnik P; Paziewska M; Purkot J; Szabelak A; Jurek M; Masny N; Dziatkiewicz I; Pronobis-Szczylik B; Piebiak A; Szymczyk A; Jarosz-Chudzik K; Bolkun L; Kozlowska K; Piszcz J; Subocz E; Halka J; Bator M; Kalicinska E; Wrobel T; Usnarska-Zubkiewicz L; Rybka J; Deren-Wagemann I; Szyca-Smieszniak M; Dybko J; Hus I; Pula B; Cichocka E; Rymko M; Zdunczyk D; Ziarkiewicz M; Basak GW; Bullinger L; Giannopoulos K
Int J Cancer; 2023 Feb; 152(4):705-712. PubMed ID: 35830214
[TBL] [Abstract][Full Text] [Related]
7. Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia A randomized study by the Swedish CLL group.
Svensson T; Kättström M; Hammarlund Y; Roth D; Andersson PO; Svensson M; Nilsson I; Rombo L; Cherif H; Kimby E
Vaccine; 2018 Jun; 36(25):3701-3707. PubMed ID: 29748028
[TBL] [Abstract][Full Text] [Related]
8. Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients--preliminary report.
Pasiarski M; Rolinski J; Grywalska E; Stelmach-Goldys A; Korona-Glowniak I; Gozdz S; Hus I; Malm A
PLoS One; 2014; 9(12):e114966. PubMed ID: 25506837
[TBL] [Abstract][Full Text] [Related]
9. Infection and immunity in chronic lymphocytic leukemia.
Tsiodras S; Samonis G; Keating MJ; Kontoyiannis DP
Mayo Clin Proc; 2000 Oct; 75(10):1039-54. PubMed ID: 11040852
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 in Patients with Chronic Lymphocytic Leukemia: What Have We Learned?
Harel R; Itchaki G
Acta Haematol; 2024; 147(1):60-72. PubMed ID: 37820599
[TBL] [Abstract][Full Text] [Related]
11. The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL).
Whitaker JA; Parikh SA; Shanafelt TD; Kay NE; Kennedy RB; Grill DE; Goergen KM; Call TG; Kendarian SS; Ding W; Poland GA
Vaccine; 2021 Feb; 39(7):1122-1130. PubMed ID: 33461835
[TBL] [Abstract][Full Text] [Related]
12. Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic.
Arellano-Llamas AA; Vela-Ojeda J; Hernandez-Caballero A
Curr Oncol Rep; 2022 Feb; 24(2):209-213. PubMed ID: 35061199
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.
Lu PJ; Hung MC; Srivastav A; Grohskopf LA; Kobayashi M; Harris AM; Dooling KL; Markowitz LE; Rodriguez-Lainz A; Williams WW
MMWR Surveill Summ; 2021 May; 70(3):1-26. PubMed ID: 33983910
[TBL] [Abstract][Full Text] [Related]
14. Reasons and consequences of COVID-19 vaccine failure in patients with chronic lymphocytic leukemia.
Morawska M
Eur J Haematol; 2022 Feb; 108(2):91-98. PubMed ID: 34717004
[TBL] [Abstract][Full Text] [Related]
15. Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study.
Qin K; Honjo K; Sherrill-Mix S; Liu W; Stoltz RM; Oman AK; Hall LA; Li R; Sterrett S; Frederick ER; Lancaster JR; Narkhede M; Mehta A; Ogunsile FJ; Patel RB; Ketas TJ; Cruz Portillo VM; Cupo A; Larimer BM; Bansal A; Goepfert PA; Hahn BH; Davis RS
PLoS Med; 2023 Jun; 20(6):e1004157. PubMed ID: 37384638
[TBL] [Abstract][Full Text] [Related]
16. Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL.
Campanella A; Capasso A; Heltai S; Taccetti C; Albi E; Herishanu Y; Haggenburg S; Chatzikonstantinou T; Doubek M; Kättström M; Giannopoulos K; Simkovic M; Moreno C; Massaia M; Bumbea H; Alshemmari S; Ranghetti P; Perotta E; Martini F; Sant'Antonio E; Colia M; Combi C; Levi S; Kater AP; Hazenberg M; Nijhof IS; Hofsink Q; Demosthenous C; Kotaskova J; Zaleska J; Vrbacky F; Raya AM; Bisogno D; Tripoli IE; Popov VM; Roman V; Stavroyianni N; Karypidou M; Scarano E; Locatelli M; Frenquelli M; Scarfò L; Stamatopoulos K; Ghia P
Am J Hematol; 2024 Apr; 99(4):745-750. PubMed ID: 38264829
[TBL] [Abstract][Full Text] [Related]
17. Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines.
Pleyer C; Ali MA; Cohen JI; Tian X; Soto S; Ahn IE; Gaglione EM; Nierman P; Marti GE; Hesdorffer C; Lotter J; Superata J; Wiestner A; Sun C
Blood; 2021 Jan; 137(2):185-189. PubMed ID: 33259596
[TBL] [Abstract][Full Text] [Related]
18. BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL.
Pleyer C; Laing KJ; Ali MA; McClurkan CL; Soto S; Ahn IE; Nierman P; Maddux E; Lotter J; Superata J; Tian X; Wiestner A; Cohen JI; Koelle DM; Sun C
Blood Adv; 2022 Mar; 6(6):1732-1740. PubMed ID: 35157769
[TBL] [Abstract][Full Text] [Related]
19. Antibody response to the 23-valent pneumococcal polysaccharide vaccine after conjugate vaccine in patients with chronic lymphocytic leukemia.
Lindström V; Aittoniemi J; Salmenniemi U; Käyhty H; Huhtala H; Sinisalo M
Hum Vaccin Immunother; 2019; 15(12):2910-2913. PubMed ID: 31216225
[TBL] [Abstract][Full Text] [Related]
20. Hybrid immunity to SARS-CoV-2 in patients with chronic lymphocytic leukemia.
Mellinghoff SC; Robrecht S; Sprute R; Mayer L; Weskamm LM; Dahlke C; Gruell H; Teipel F; Schlößer HA; Siepmann K; Thelen M; Fink AM; Fischer K; Klein F; Addo MM; Kolovou A; Cornely OA; Eichhorst B; Hallek M; Langerbeins P
Eur J Haematol; 2024 May; 112(5):788-793. PubMed ID: 38311570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
